258 related articles for article (PubMed ID: 19800577)
21. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
[TBL] [Abstract][Full Text] [Related]
22. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK
Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772
[TBL] [Abstract][Full Text] [Related]
23. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.
Li Y; Chitnis N; Nakagawa H; Kita Y; Natsugoe S; Yang Y; Li Z; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
Cancer Discov; 2015 Mar; 5(3):288-303. PubMed ID: 25582697
[TBL] [Abstract][Full Text] [Related]
24. Loss of PRDM11 promotes MYC-driven lymphomagenesis.
Fog CK; Asmar F; Côme C; Jensen KT; Johansen JV; Kheir TB; Jacobsen L; Friis C; Louw A; Rosgaard L; Øbro NF; Marquart HV; Anthonsen K; Braat AK; van Lohuizen M; Ralfkiaer E; Grønbæk K; Lund AH
Blood; 2015 Feb; 125(8):1272-81. PubMed ID: 25499759
[TBL] [Abstract][Full Text] [Related]
25. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
[TBL] [Abstract][Full Text] [Related]
26. A large-scale RNAi screen in human cells identifies new components of the p53 pathway.
Berns K; Hijmans EM; Mullenders J; Brummelkamp TR; Velds A; Heimerikx M; Kerkhoven RM; Madiredjo M; Nijkamp W; Weigelt B; Agami R; Ge W; Cavet G; Linsley PS; Beijersbergen RL; Bernards R
Nature; 2004 Mar; 428(6981):431-7. PubMed ID: 15042092
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
28. FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.
Bouchard C; Lee S; Paulus-Hock V; Loddenkemper C; Eilers M; Schmitt CA
Genes Dev; 2007 Nov; 21(21):2775-87. PubMed ID: 17974917
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival.
Arrate MP; Vincent T; Odvody J; Kar R; Jones SN; Eischen CM
Cancer Res; 2010 Jul; 70(14):6083-92. PubMed ID: 20587524
[TBL] [Abstract][Full Text] [Related]
30. PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice.
Weber J; de la Rosa J; Grove CS; Schick M; Rad L; Baranov O; Strong A; Pfaus A; Friedrich MJ; Engleitner T; Lersch R; Öllinger R; Grau M; Menendez IG; Martella M; Kohlhofer U; Banerjee R; Turchaninova MA; Scherger A; Hoffman GJ; Hess J; Kuhn LB; Ammon T; Kim J; Schneider G; Unger K; Zimber-Strobl U; Heikenwälder M; Schmidt-Supprian M; Yang F; Saur D; Liu P; Steiger K; Chudakov DM; Lenz G; Quintanilla-Martinez L; Keller U; Vassiliou GS; Cadiñanos J; Bradley A; Rad R
Nat Commun; 2019 Mar; 10(1):1415. PubMed ID: 30926791
[TBL] [Abstract][Full Text] [Related]
31. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
Bertwistle D; Sherr CJ
Blood; 2007 Jan; 109(2):792-4. PubMed ID: 16968893
[TBL] [Abstract][Full Text] [Related]
33. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
[TBL] [Abstract][Full Text] [Related]
34. [Tumor suppressor genes].
Kuchino Y
Nihon Rinsho; 1994 Dec; 52(12):3319-29. PubMed ID: 7853729
[TBL] [Abstract][Full Text] [Related]
35. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
Kongkham PN; Northcott PA; Croul SE; Smith CA; Taylor MD; Rutka JT
Oncogene; 2010 May; 29(20):3017-24. PubMed ID: 20208569
[TBL] [Abstract][Full Text] [Related]
36. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
37. Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell model.
McClendon AK; Dean JL; Ertel A; Knudsen ES
PLoS One; 2010 Jan; 5(1):e8558. PubMed ID: 20049321
[TBL] [Abstract][Full Text] [Related]
38. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling.
Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C
PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159
[TBL] [Abstract][Full Text] [Related]
39. Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
Hensel J; Duex JE; Owens C; Dancik GM; Edwards MG; Frierson HF; Theodorescu D
Mol Cancer Res; 2015 Sep; 13(9):1306-15. PubMed ID: 26078295
[TBL] [Abstract][Full Text] [Related]
40. The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor Metabolism.
Izreig S; Samborska B; Johnson RM; Sergushichev A; Ma EH; Lussier C; Loginicheva E; Donayo AO; Poffenberger MC; Sagan SM; Vincent EE; Artyomov MN; Duchaine TF; Jones RG
Cell Rep; 2016 Aug; 16(7):1915-28. PubMed ID: 27498867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
